Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Powles

Showing results (21-30 of 275) with videos related to

Pageof 28
Sort By:
International Journal of Fertility and Women'S Medicine|February 3, 2007
Is raloxifene ready to be used for prevention of breast cancer?Trevor J Powles
Proceedings of the Royal Society of Medicine|March 1, 1977
Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancerT J Powles
Journal of the National Cancer Institute|December 21, 2000
Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized studyT J Powles
Lancet (London, England)|December 11, 2012
Extended adjuvant tamoxifen for breast cancer--a new era?Trevor J Powles
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Prognostic impact of amenorrhoea after adjuvant chemotherapyT J Powles
Lancet (London, England)|July 8, 1989
Oral contraceptives and breast cancerT J Powles
Clinical Oncology|June 1, 1981
Adjuvant therapy for primary breast cancerT J Powles
Nature Reviews. Cancer|October 3, 2002
Anti-oestrogenic prevention of breast cancer--the make or break pointTrevor J Powles
Lancet (London, England)|November 7, 1992
The case for clinical trials of tamoxifen for prevention of breast cancerT J Powles
Nature Clinical Practice. Oncology|December 2, 2006
Do we have a clinically useful breast cancer risk reduction agent for healthy women?Trevor J Powles
Pageof 28

Showing results (21-30 of 275) with videos related to

Sort By:
Pageof 28
International Journal of Fertility and Women'S Medicine|February 3, 2007
Is raloxifene ready to be used for prevention of breast cancer?Trevor J Powles
Proceedings of the Royal Society of Medicine|March 1, 1977
Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancerT J Powles
Journal of the National Cancer Institute|December 21, 2000
Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized studyT J Powles
Lancet (London, England)|December 11, 2012
Extended adjuvant tamoxifen for breast cancer--a new era?Trevor J Powles
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Prognostic impact of amenorrhoea after adjuvant chemotherapyT J Powles
Lancet (London, England)|July 8, 1989
Oral contraceptives and breast cancerT J Powles
Clinical Oncology|June 1, 1981
Adjuvant therapy for primary breast cancerT J Powles
Nature Reviews. Cancer|October 3, 2002
Anti-oestrogenic prevention of breast cancer--the make or break pointTrevor J Powles
Lancet (London, England)|November 7, 1992
The case for clinical trials of tamoxifen for prevention of breast cancerT J Powles
Nature Clinical Practice. Oncology|December 2, 2006
Do we have a clinically useful breast cancer risk reduction agent for healthy women?Trevor J Powles
Pageof 28